Literature DB >> 11349222

Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder.

S Kravchick1, R Gal, S Cytron, R Peled, Y Weissman, E Mukamel, R Koren.   

Abstract

The progression of bladder cancer to invasive disease is highly dependent on its ability to penetrate basement membrane of urothelium. Studies on diabetic nephropathy have shown a reduction in proteoglycan content of the glomerular basement membrane. Based on the well-known fact that proteoglycans are one of the main components of basement membrane and extracellular matrix we assessed the relationship between diabetes mellitus, bladder cancer incidence and its behavior. These studies include 252 patients with microscopically confirmed transitional cell carcinoma of bladder, and 549 patients with other urological disorders who served as controls. The prevalence of diabetes mellitus in each group was assessed. The group of patients suffering from transitional cell carcinoma was divided according to etiological risk factors such as cigarette smoking, diabetes and patients that were non-smokers and did not suffer from diabetes mellitus. We assessed the features of bladder cancer behavior in each group. Logistic regression model estimation for statistical analysis was used, with transitional cell carcinoma as a dependent binary variable and age, sexes smoking and diabetes as independent variables. Statistical significance was considered at two levels: p <or=0.001 and p <or=0.05. Odds ratio (OR) adjusted to age, sex, cigarette smoking, diabetes mellitus and 95% Confidence Interval (CI) were calculated for TCC. In the TCC group 22.2% of the patients suffered from diabetes mellitus. In the control group 10.38% suffered from diabetes mellitus. Logistic regression analysis, OR and 95% CI showed a statistically significant relationship between diabetes and TCC. These data are comparable only with smoking (OR 2.3; 95% CI 1.6 3.5 and OR 1.58; 95% CI 1.08 2.4 correspondingly). Based on these data we suggest that diabetes mellitus may be considered an etiological risk factor for bladder cancer development.

Entities:  

Mesh:

Year:  2001        PMID: 11349222     DOI: 10.1007/bf03032606

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases.

Authors:  P Asten; J Barrett; D Symmons
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

2.  Bladder surface glycosaminoglycans: an epithelial permeability barrier.

Authors:  C L Parsons; D Boychuk; S Jones; R Hurst; H Callahan
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

Review 3.  Epidemiology of bladder cancer.

Authors:  D T Silverman; P Hartge; A S Morrison; S S Devesa
Journal:  Hematol Oncol Clin North Am       Date:  1992-02       Impact factor: 3.722

4.  Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.

Authors:  E M Messing
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

5.  Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes.

Authors:  N Attia; S Caprio; T W Jones; R Heptulla; J Holcombe; D Silver; R S Sherwin; W V Tamborlane
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

6.  Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.

Authors:  V B Lokeshwar; M J Young; G Goudarzi; N Iida; A I Yudin; G N Cherr; M G Selzer
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

7.  Epidermal growth factor in urine from patients with urinary bladder tumors.

Authors:  J K Kristensen; G Lose; F Lund; E Nexø
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

Review 8.  Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.

Authors:  I Vlodavsky; A Eldor; A Haimovitz-Friedman; Y Matzner; R Ishai-Michaeli; O Lider; Y Naparstek; I R Cohen; Z Fuks
Journal:  Invasion Metastasis       Date:  1992

Review 9.  Heparanases and tumor metastasis.

Authors:  M Nakajima; T Irimura; G L Nicolson
Journal:  J Cell Biochem       Date:  1988-02       Impact factor: 4.429

10.  Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies.

Authors:  E M Messing; P Hanson; P Ulrich; E Erturk
Journal:  J Urol       Date:  1987-11       Impact factor: 7.450

View more
  9 in total

1.  Diabetes mellitus and risk of bladder cancer: a meta-analysis.

Authors:  S C Larsson; N Orsini; K Brismar; A Wolk
Journal:  Diabetologia       Date:  2006-10-05       Impact factor: 10.122

2.  Diabetes mellitus and bladder cancer--an epidemiological relationship?

Authors:  Yeung Ng; I Husain; N Waterfall
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

Review 3.  Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.

Authors:  Hong Fang; Baodong Yao; Yujie Yan; Huilin Xu; Yinan Liu; Hongmei Tang; Jie Zhou; Lili Cao; Weijie Wang; Jinling Zhang; Liyun Zhao; Xi Chen; Fen Zhang; Yanping Zhao
Journal:  Diabetes Technol Ther       Date:  2013-11       Impact factor: 6.118

Review 4.  Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.

Authors:  Zhaowei Zhu; Xianjin Wang; Zhoujun Shen; Yingli Lu; Shan Zhong; Chen Xu
Journal:  BMC Cancer       Date:  2013-06-26       Impact factor: 4.430

Review 5.  Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.

Authors:  Sadaf Raana; Aqeel Javeed
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

Review 6.  CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis.

Authors:  Jakob Starup-Linde; Oystein Karlstad; Stine Aistrup Eriksen; Peter Vestergaard; Heleen K Bronsveld; Frank de Vries; Morten Andersen; Anssi Auvinen; Jari Haukka; Vidar Hjellvik; Marloes T Bazelier; Anthonius de Boer; Kari Furu; Marie L De Bruin
Journal:  Curr Drug Saf       Date:  2013-11

7.  The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects.

Authors:  Xiao-Fan Peng; Xiang-Yu Meng; Cheng Wei; Zhen-Hua Xing; Jia-Bin Huang; Zhen-Fei Fang; Xin-Qun Hu; Qi-Ming Liu; Zhao-Wei Zhu; Sheng-Hua Zhou
Journal:  Cancer Manag Res       Date:  2018-11-26       Impact factor: 3.989

8.  Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience.

Authors:  Bartosz Dybowski; Krzysztof Ossoliński; Anna Ossolińska; Michał Peller; Ewa Bres-Niewada; Piotr Radziszewski
Journal:  Cent European J Urol       Date:  2015-10-15

9.  Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.

Authors:  Hua-Fen Chen; Shwe-Winn Chen; Ya-Hui Chang; Chung-Yi Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.